Loading stock data…
SI-BONE (SIBN)
$16.88-0.45 (-2.60%)
Market ClosedLast close Jun 29
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
SI-BONE, Inc. in the Healthcare sector is trading at $16.88 with a market capitalization of $672M. Wall Street consensus targets $24.12 (8 analysts), implying a +42.9% move over the next 12 months. The stock is currently 23% below its 52-week high of $21.89, remaining 7.4% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +42.9% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $52.59M↓ | $56.35M↑ | $48.66M | $48.63M↑ | $47.29M |
| Gross Profit | $41.94M↓ | $44.53M↑ | $38.85M↑ | $38.81M↑ | $37.70M |
| Operating Income | -$5.09M↓ | -$2.46M↑ | -$5.38M↑ | -$7.00M↑ | -$7.48M |
| Net Income | -$4.33M↓ | -$1.64M↑ | -$4.57M↑ | -$6.15M↑ | -$6.54M |
Peer Comparison
JNJUNHPFE
Fundamentals
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented tita...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$671.89M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-9.33%
Volume
Today's trading volume
471,169
Recent News
Bears are Losing Control Over Si-Bone (SIBN), Here's Why It's a 'Buy' Now
Si-Bone (SIBN) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Wall Street Analysts Predict a 71.13% Upside in Si-Bone (SIBN): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 71.1% in Si-Bone (SIBN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
How Much Upside is Left in Si-Bone (SIBN)? Wall Street Analysts Think 65.27%
The consensus price target hints at a 65.3% upside potential for Si-Bone (SIBN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Why Si-Bone Stock Soared by Almost 20% on Tuesday
It's off to a roaring start as far as the financial year is concerned.
SI-BONE Inc (SIBN) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...
SI-BONE Inc (SIBN) reports impressive international revenue growth and raises full-year guidance, while navigating challenges and capitalizing on new opportunities.